NCDDGNational Cooperative Drug Discovery Groups
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The development of DB289 for the treatment of PCP was sponsored in part by a National Cooperative Drug Discovery Groups (NCDDG) grant from the National Institutes of Health, US Department of Human Health and Services, to the University of North Carolina at Chapel Hill.
"The initial NCDDG grant demonstrated that dicationic molecules have excellent activity against fungi that cause serious diseases in humans," said Dr.